Disclosures for "Observational Study of Inebilizumab as a Salvage Therapy for Acute Optic Neuritis in Neuromyelitis Optica Spectrum Disorder (NMOSD-ON)"
-
The institution of Dr. Yang has received research support from Guangdong Provincial Natural Science Foundation.
-
Ms. Cao has nothing to disclose.
-
Ms. Xu has nothing to disclose.